In conclusion, although we have made significant progress in understanding ILC biology, their impact on tumor development and progression is still controversial; a number of studies indicate TGF-β as a key regulator of these innate lymphocytes but additional studies are needed to clarify how this cytokine may impact on their functions and plasticity in cancer. Here, TGFB1 is linked to neoplasm.